Mauricio De Sant Anna Jr

Mauricio De Sant Anna Jr

Auto-generated profile, based on publicly available information

Mauricio De Sant Anna Jr

Instituto Nacional de Câncer - INCA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2011 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
AMAdalgiza Mafra Moreno
Adalgiza Mafra Moreno
RCRenata Rt Castro
Renata Rt Castro
PSPedro Ps Sorares
Pedro Ps Sorares
MAMauricio Sant' Anna
Mauricio Sant' Anna
SCSergio Ld Cravo
Sergio Ld Cravo
ANAntônio Cl Nóbrega
Antônio Cl Nóbrega
Background: The treatment of coronary artery disease (CAD) seeks to reduce or prevent its complications and decrease morbidity and mortality. For certain subgroups of patients, coronary artery bypass graft surgery (CABG) may accomplish these goals. The objective of this study was to assess the pulmonary function in the CABG postoperative period of patients treated with a physiotherapy protocol. Methods: Forty-two volunteers with an average age of 63 ± 2 years were included and separated into three groups: healthy volunteers (n = 09), patients with CAD (n = 9) and patients who underwent CABG (n = 20). Patients from the CABG group received preoperative and postoperative evaluations on days 3, 6, 15 and 30. Patients from the CAD group had evaluations on days 1 and 30 of the study, and the healthy volunteers were evaluated on day 1. Pulmonary function was evaluated by measuring forced vital capacity (FVC), maximum expiratory pressure (MEP) and Maximum inspiratory pressure (MIP). Results: After CABG, there was a significant decrease in pulmonary function (p < 0.05), which was the worst on postoperative day 3 and returned to the preoperative baseline on postoperative day 30. Conclusion: Pulmonary function decreased after CABG. Pulmonary function was the worst on postoperative day 3 and began to improve on postoperative day 15. Pulmonary function returned to the preoperative baseline on postoperative day 30.

1 January 2019 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
MJMauricio de Sant’aNna Jr
Mauricio de Sant’aNna Jr
RCRenata Ferreira Carvalhal
Renata Ferreira Carvalhal
FOFernando da Franca Bastos de Oliveira
Fernando da Franca Bastos de Oliveira
WZWalter Araújo Zin
Walter Araújo Zin
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
FGFernando Silva Guimarães
Fernando Silva Guimarães
RESUMO Objetivo avaliar os diferentes componentes da resistência do sistema respiratório e a força muscular respiratória, bem como investigar a ocorrência de limitação de fluxo expiratório (LFE) de pacientes obesos mórbidos (OM) na posição sentada. Métodos a amostra foi composta de OM (IMC ≥ 40 kg/m2) e de indivíduos não obesos (NO) com IMC entre 18 e 30 kg/m2. O protocolo foi composto de: avaliação antropométrica e da função respiratória (espirometria, pressões inspiratória (PIM) e expiratória máximas (PEM) e oscilometria de impulso). Na comparação entre os grupos, foi utilizado o teste T para amostras não pareadas. As correlações foram avaliadas pelo teste de Pearson, e o nível de significância foi de 5%. Resultados Foram avaliados 50 OM (idade 40,0 ± 10,4 anos, 1,64 ± 0,09 m, 138,8 ± 33,6 kg e 50,7 ± 8,9 kg/m2), além de 30 NO (idade 37,6 ± 11,5 anos, 1,67 ± 0,09 m, 65,2 ± 10,3 kg e 23,2 ± 22 kg/m2). Os OM apresentaram maiores valores de resistência total, central, de vias aéreas, tecidual e periférica quando comparados aos NO. Nenhum paciente apresentou LFE. A circunferência abdominal se associou com variáveis espirométricas PIM e PEM. A relação cintura-quadril se correlacionou com variáveis de mecânica respiratória, além das espirométricas PIM e PEM. Conclusões pacientes com obesidade mórbida e sem padrão espirométrico obstrutivo apresentam aumento nas resistências total, de vias aéreas, periférica e tecidual do sistema respiratório quando comparados a não obesos. Esses indivíduos, entretanto, não apresentam limitação de fluxo expiratório e redução da força muscular respiratória.

29 August 2014 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
AMAdalgiza Mafra Moreno
Adalgiza Mafra Moreno
RCR.R.T. Castro
R.R.T. Castro
BSBruno Moreira Silva
Bruno Moreira Silva
HVH. Villacorta
H. Villacorta
MJM. Sant'ANna Junior
M. Sant'ANna Junior
ANA.C.L. Nóbrega
A.C.L. Nóbrega
The purpose of this study was to determine the effect of respiratory muscle fatigue on intercostal and forearm muscle perfusion and oxygenation in patients with heart failure. Five clinically stable heart failure patients with respiratory muscle weakness (age, 66±12 years; left ventricle ejection fraction, 34±3%) and nine matched healthy controls underwent a respiratory muscle fatigue protocol, breathing against a fixed resistance at 60% of their maximal inspiratory pressure for as long as they could sustain the predetermined inspiratory pressure. Intercostal and forearm muscle blood volume and oxygenation were continuously monitored by near-infrared spectroscopy with transducers placed on the seventh left intercostal space and the left forearm. Data were compared by two-way ANOVA and Bonferroni correction. Respiratory fatigue occurred at 5.1±1.3 min in heart failure patients and at 9.3±1.4 min in controls (P0.05). Respiratory fatigue in heart failure reduced intercostal and forearm muscle blood volume (P<0.05) along with decreased tissue oxygenation both in intercostal (heart failure, -2.6±1.6%; controls, +1.6±0.5%; P<0.05) and in forearm muscles (heart failure, -4.5±0.5%; controls, +0.5±0.8%; P<0.05). These results suggest that respiratory fatigue in patients with heart failure causes an oxygen demand/delivery mismatch in respiratory muscles, probably leading to a reflex reduction in peripheral limb muscle perfusion, featuring a respiratory metaboreflex.

4 July 2018 in Neurology International
Verified
Journal Article
Open access
PDF file
MFMarcos R.G. De Freitas
Marcos R.G. De Freitas
MOMarco Orsini
Marco Orsini
AAAlexandra Prufer De Queiroz Campos Araújo
Alexandra Prufer De Queiroz Campos Araújo
LJLuiz João Abraão Jr.
Luiz João Abraão Jr.
GBGilberto Miranda Barbosa
Gilberto Miranda Barbosa
MJMauricio Da Sant’Anna Jr.
Mauricio Da Sant’Anna Jr.
Allgrove or triple A syndrome (AS or AAA) is a rare autosomal recessive syndrome with variable phenotype due to mutations in AAAS gene which encodes a protein called ALADIN. Generally, it’s characterized by of adrenal insufficiency in consequence of adrenocorticotropic hormone (ACTH) resistance, besides of achalasia, and alacrimia. Neurologic features are varied and have been the subject of several case reports and reviews. A few cases of Allgrove syndrome with motor neuron disease have been already described. A 25-year-old white man, at the age of four, presented slowly progressive distal amyotrophy and weakness, autonomic dysfunction, dysphagia and lack of tears. He suffered later of orthostatic hypotension and erectile dysfunction. He presented distal amytrophy in four limbs, tongue myofasiculations, alacrimia, hoarseness and dysphagia due to achalasia. The ENMG showed generalized denervation with normal conduction velocities. Genetic testing revealed 2 known pathogenic variants in the AAAS gene (c.938T>C and c.1144_1147delTCTG). Our case presented a distal spinal amyotrophy with slow evolution and symptoms and signs of AS with a mutation in AAAS gen. Some cases of motor neuron disease, as ours, may be due to AAS. Early diagnosis is extremely important for symptomatic treatment.

1 January 2015 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Closed access
MJMaurício de Sant Anna Junior
Maurício de Sant Anna Junior
JCJoão Regis Ivar Carneiro
João Regis Ivar Carneiro
RCRenata Ferreira Carvalhal
Renata Ferreira Carvalhal
DTDiego de Faria Magalhães Torres
Diego de Faria Magalhães Torres
GCGustavo Gavina da Cruz
Gustavo Gavina da Cruz
FGFernando Silva Guimarães
Fernando Silva Guimarães

1 July 2016 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MOMarco Orsini
Marco Orsini
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
FGFernando S. Guimarães
Fernando S. Guimarães
MFMarcos R. G. Freitas
Marcos R. G. Freitas
ONOsvaldo J. M. Nascimento
Osvaldo J. M. Nascimento
PRPedro Ribeiro
Pedro Ribeiro
Post-polio syndrome (PPS) is a condition that affects polio survivors years after recovery from an initial acute attack of the poliomyelitis virus. Most often, polio survivors experience a gradual new weakening in muscles that were previously affected by the polio infection. The actual incidence of cardiovascular diseases (CVDs) in individuals suffering from PPS is not known. However, there is a reason to suspect that individuals with PPS might be at increased risk. Method A search for papers was made in the databases Bireme, Scielo and Pubmed with the following keywords: post polio syndrome, cardiorespiratory and rehabilitation in English, French and Spanish languages. Although we targeted only seek current studies on the topic in question, only the relevant (double-blind, randomized-controlled and consensus articles) were considered. Results and Discussion Certain features of PPS such as generalized fatigue, generalized and specific muscle weakness, joint and/or muscle pain may result in physical inactivity deconditioning obesity and dyslipidemia. Respiratory difficulties are common and may result in hypoxemia. Conclusion Only when evaluated and treated promptly, somE patients can obtain the full benefits of the use of respiratory muscles aids as far as quality of life is concerned.